Today: 22 March 2026
Browse Category

NYSEA:TOVX 15 October 2025

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics shares surged 92% to $0.84 on Oct. 15 after reporting its VCN-01 plus chemotherapy met primary survival endpoints in metastatic pancreatic cancer, prompting a planned Phase 3 trial. The company will present expanded VIRAGE Phase 2b data at ESMO 2025 and interim SYN-004 safety results at IDWeek 2025. Theriva held $12.1 million in cash as of June 30, with a $7.5 million offering closed in May.
15 October 2025

Stock Market Today

  • GoDaddy Shares Trade at Discount Despite Strong Cash Flow and Growth
    March 22, 2026, 6:56 AM EDT. GoDaddy (GDDY) stock is trading 33% below its 3-month high, facing pressure after 2026 revenue guidance missed expectations and concerns over AI competition. Yet, the company shows solid fundamentals with 8.3% revenue growth, robust free cash flow projected at $1.8 billion in 2026, and a cash flow yield of 13.8%, significantly above the S&P median. Operating margins stand strong at 23%, and valuation ratios remain attractive with a price-to-earnings ratio of 13.1 versus the S&P's 23.4. Historical market downturns hit GDDY shares hard-down up to 47% during Covid selloff-highlighting risk despite underlying strength. Investors attracted to cash-generating tech stocks may find GoDaddy appealing for growth or shareholder returns through dividends or buybacks.
Go toTop